BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 32892005)

  • 1. Dysregulated lipid and fatty acid metabolism link perfluoroalkyl substances exposure and impaired glucose metabolism in young adults.
    Chen Z; Yang T; Walker DI; Thomas DC; Qiu C; Chatzi L; Alderete TL; Kim JS; Conti DV; Breton CV; Liang D; Hauser ER; Jones DP; Gilliland FD
    Environ Int; 2020 Dec; 145():106091. PubMed ID: 32892005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perfluoroalkyl substances, metabolomic profiling, and alterations in glucose homeostasis among overweight and obese Hispanic children: A proof-of-concept analysis.
    Alderete TL; Jin R; Walker DI; Valvi D; Chen Z; Jones DP; Peng C; Gilliland FD; Berhane K; Conti DV; Goran MI; Chatzi L
    Environ Int; 2019 May; 126():445-453. PubMed ID: 30844580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Signatures of Youth Exposure to Mixtures of Per- and Polyfluoroalkyl Substances: A Multi-Cohort Study.
    Goodrich JA; Walker DI; He J; Lin X; Baumert BO; Hu X; Alderete TL; Chen Z; Valvi D; Fuentes ZC; Rock S; Wang H; Berhane K; Gilliland FD; Goran MI; Jones DP; Conti DV; Chatzi L
    Environ Health Perspect; 2023 Feb; 131(2):27005. PubMed ID: 36821578
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association of exposure to multiple perfluoroalkyl and polyfluoroalkyl substances and glucose metabolism in National Health and Nutrition Examination Survey 2017-2018.
    Tian Q; Yang Y; An Q; Li Y; Wang Q; Zhang P; Zhang Y; Zhang Y; Mu L; Lei L
    Front Public Health; 2024; 12():1370971. PubMed ID: 38633237
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exposure to per- and polyfluoroalkyl substances in early pregnancy, risk of gestational diabetes mellitus, potential pathways, and influencing factors in pregnant women: A nested case-control study.
    Zang L; Liu X; Xie X; Zhou X; Pan Y; Dai J
    Environ Pollut; 2023 Jun; 326():121504. PubMed ID: 36965679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Per- and polyfluoroalkyl substance (PFAS) exposure, maternal metabolomic perturbation, and fetal growth in African American women: A meet-in-the-middle approach.
    Chang CJ; Barr DB; Ryan PB; Panuwet P; Smarr MM; Liu K; Kannan K; Yakimavets V; Tan Y; Ly V; Marsit CJ; Jones DP; Corwin EJ; Dunlop AL; Liang D
    Environ Int; 2022 Jan; 158():106964. PubMed ID: 34735953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Associations between per- and polyfluoroalkyl substances (PFAS) and diabetes in two population-based cohort studies from Sweden.
    Dunder L; Salihovic S; Elmståhl S; Lind PM; Lind L
    J Expo Sci Environ Epidemiol; 2023 Sep; 33(5):748-756. PubMed ID: 36964247
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemic-specific association of maternal exposure to per- and polyfluoroalkyl substances (PFAS) and their components with maternal glucose metabolism: A cross-sectional analysis in a birth cohort from Hong Kong.
    Yang A; Tam CHT; Wong KK; Ozaki R; Lowe WL; Metzger BE; Chow E; Tam WH; Wong CKC; Ma RCW
    Sci Total Environ; 2024 Mar; 917():170220. PubMed ID: 38278268
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Environmental exposure to perfluoroalkyl substances in early pregnancy, maternal glucose homeostasis and the risk of gestational diabetes: A prospective cohort study.
    Yu G; Jin M; Huang Y; Aimuzi R; Zheng T; Nian M; Tian Y; Wang W; Luo Z; Shen L; Wang X; Du Q; Xu W; Zhang J;
    Environ Int; 2021 Nov; 156():106621. PubMed ID: 33984575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of PFAS exposure on prevalence of immune-mediated diseases in adults in the Czech Republic.
    Rudzanova B; Vlaanderen J; Kalina J; Piler P; Zvonar M; Klanova J; Blaha L; Adamovsky O
    Environ Res; 2023 Jul; 229():115969. PubMed ID: 37116680
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-targeted metabolomics and associations with per- and polyfluoroalkyl substances (PFAS) exposure in humans: A scoping review.
    Guo P; Furnary T; Vasiliou V; Yan Q; Nyhan K; Jones DP; Johnson CH; Liew Z
    Environ Int; 2022 Apr; 162():107159. PubMed ID: 35231839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic Perturbations Associated with an Exposure Mixture of Per- and Polyfluoroalkyl Substances in the Atlanta African American Maternal-Child Cohort.
    Liang D; Taibl KR; Dunlop AL; Barr DB; Ryan PB; Everson T; Huels A; Tan Y; Panuwet P; Kannan K; Marsit C; Jones DP; Eick SM
    Environ Sci Technol; 2023 Oct; 57(43):16206-16218. PubMed ID: 37857362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associations between Mixture of Perfluoroalkyl Substances and Lipid Profile in a Highly Exposed Adult Community in the Veneto Region.
    Batzella E; Zare Jeddi M; Pitter G; Russo F; Fletcher T; Canova C
    Int J Environ Res Public Health; 2022 Sep; 19(19):. PubMed ID: 36231722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prenatal and postnatal exposure to PFAS and cardiometabolic factors and inflammation status in children from six European cohorts.
    Papadopoulou E; Stratakis N; Basagaña X; Brantsæter AL; Casas M; Fossati S; Gražulevičienė R; Småstuen Haug L; Heude B; Maitre L; McEachan RRC; Robinson O; Roumeliotaki T; Sabidó E; Borràs E; Urquiza J; Vafeiadi M; Zhao Y; Slama R; Wright J; Conti DV; Vrijheid M; Chatzi L
    Environ Int; 2021 Dec; 157():106853. PubMed ID: 34500361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations between exposure to a mixture of perfluoroalkyl and polyfluoroalkyl substances and age at menarche in adolescent girls utilizing three statistical models.
    Guo M; Yu Y; Liu H; Zhu C
    Chemosphere; 2023 Sep; 335():139054. PubMed ID: 37247673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exposure to per- and polyfluoroalkyl substances as a risk factor for gestational diabetes mellitus through interference with glucose homeostasis.
    Xu C; Zhang L; Zhou Q; Ding J; Yin S; Shang X; Tian Y
    Sci Total Environ; 2022 Sep; 838(Pt 4):156561. PubMed ID: 35691348
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations between both legacy and alternative per- and polyfluoroalkyl substances and glucose-homeostasis: The Isomers of C8 health project in China.
    Zhang YT; Zeeshan M; Su F; Qian ZM; Dee Geiger S; Edward McMillin S; Wang ZB; Dong PX; Ou YQ; Xiong SM; Shen XB; Zhou PE; Yang BY; Chu C; Li QQ; Zeng XW; Feng WR; Zhou YZ; Dong GH
    Environ Int; 2022 Jan; 158():106913. PubMed ID: 34624590
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma concentrations of per- and polyfluoroalkyl substances are associated with perturbations in lipid and amino acid metabolism.
    Prince N; Begum S; Mínguez-Alarcón L; Génard-Walton M; Huang M; Soeteman DI; Wheelock C; Litonjua AA; Weiss ST; Kelly RS; Lasky-Su J
    Chemosphere; 2023 May; 324():138228. PubMed ID: 36878362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perfluoroalkyl substances and sex hormones in postmenopausal women: NHANES 2013-2016.
    Wang Y; Aimuzi R; Nian M; Zhang Y; Luo K; Zhang J
    Environ Int; 2021 Apr; 149():106408. PubMed ID: 33548847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. PPARα/ACOX1 as a novel target for hepatic lipid metabolism disorders induced by per- and polyfluoroalkyl substances: An integrated approach.
    Yang W; Ling X; He S; Cui H; Yang Z; An H; Wang L; Zou P; Chen Q; Liu J; Ao L; Cao J
    Environ Int; 2023 Aug; 178():108138. PubMed ID: 37572494
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.